前交叉韧带重建是否影响骨软骨同种异体移植的结果?平均随访6年的配对队列研究
本研究为证据等级3级的队列研究,比较31膝有前交叉韧带重建史的骨软骨同种异体移植(OCA)与62膝无前交叉韧带重建史的单纯OCA移植(完整前交叉韧带),按年龄、诊断、手术年份和移植物大小配对。结果显示两组临床失败率均为9.7%(P≤.999),5年和10年移植物生存率分别为94.7%和82.3% vs 93.4%和79.6%(P=.979),作者结论为前交叉韧带重建史未影响OCA移植的结果。
要点
- 有前交叉韧带重建史的OCA移植与无此史的OCA移植临床失败率均为9.7%(P≤.999)。
- 两组5年生存率分别为94.7%和93.4%,10年生存率分别为82.3%和79.6%(P=.979)。
- 前交叉韧带重建史未影响OCA移植的功能结局和移植物生存率。
核心结论
- 骨软骨同种异体移植治疗软骨损伤可靠有效,无论是否有前交叉韧带重建史,均表现为结局评分改善、长期生存率和高满意度。
- 有前交叉韧带重建史未影响骨软骨同种异体移植的结果。
研究设计与样本
- 队列研究,证据等级3级。
- 比较31膝有前交叉韧带重建史的骨软骨同种异体移植(OCA合并ACL组)与62膝无前交叉韧带重建史的单纯骨软骨同种异体移植(OCA组,前交叉韧带完整)。
- 两组按年龄、诊断、手术年份和移植物大小配对,最低随访2年。
主要发现
- 临床失败(定义为翻修OCA移植或转为关节置换)在OCA合并ACL组为31膝中3膝(9.7%),在OCA组为62膝中6膝(9.7%)(P≤.999)。
- OCA移植物5年和10年生存率在OCA合并ACL组分别为94.7%和82.3%,在OCA组分别为93.4%和79.6%(P=.979)。
- 所有膝关节(移植物在位)平均随访6.2±3.3年。
- 所有主观结局指标从术前至末次随访的变化值(差值评分)在OCA组更大,但均无统计学显著差异。
- 对OCA移植结果的满意度在OCA合并ACL组为78.3%,在OCA组为71.7%(P=.551)。
关键数值与推荐
- 临床失败定义为翻修OCA移植或转为关节置换。
- 主观结局指标包括国际膝关节文献委员会(IKDC)评分、膝关节损伤和骨关节炎结局评分(KOOS)及患者满意度。
临床怎么用
- 原文未据此给出推荐,仅报告骨软骨同种异体移植治疗软骨损伤可靠有效,无论是否有前交叉韧带重建史。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have evaluated the influence of anterior cruciate ligament (ACL) reconstruction on the outcome of cartilage repair. Hypothesis/Purpose: The purpose was to investigate the association between ACL reconstruction and functional outcomes after osteochondral allograft (OCA) transplantation. The hypothesis was that patients treated with OCA transplantation who had a history of ACL reconstruction would have inferior clinical outcomes and lower osteochondral graft survivorship when compared with a matched group of patients undergoing OCA transplantation without a history of ACL reconstruction. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: This study compared 31 knees that underwent OCA transplantation with a history of ACL reconstruction (OCA and ACL group) and 62 knees treated with isolated OCA transplantation (OCA group) that had an intact ACL. Groups were matched by age, diagnosis, year of surgery, and graft size. Minimum follow-up was 2 years. Frequency and type of reoperation were assessed. Clinical failure was defined as revision OCA transplantation or conversion to arthroplasty. Subjective outcome measures included International Knee Documentation Committee scores, Knee injury and Osteoarthritis Outcome Scores, and patient satisfaction. RESULTS: Clinical failure occurred in 3 of 31 knees (9.7%) in the OCA and ACL group and 6 of 62 knees (9.7%) in the OCA group ( P ≤ .999). Five- and 10-year survivorship of the OCA was 94.7% and 82.3% for the OCA and ACL group and 93.4% and 79.6% for OCA group, respectively ( P = .979). Mean follow-up was 6.2 ± 3.3 years among all knees with grafts in situ. Changes from preoperative to latest follow-up visit (difference scores) on all subjective outcome measures were greater in the OCA group; however, none of the difference scores were statistically significant. Satisfaction with the results of OCA transplantation was reported in 78.3% of the OCA and ACL group and 71.7% of the OCA group ( P = .551). CONCLUSION: Treatment of cartilage lesions with OCA transplantation proved to be reliable and effective regardless of a history of ACL reconstruction as demonstrated by the improvements in outcome scores, long survivorship, and high satisfaction rates. History of ACL reconstruction did not influence outcome of OCA transplantation.
引用
- Tírico LEP, McCauley JC, Pulido PA, et al. Does Anterior Cruciate Ligament Reconstruction Affect the Outcome of Osteochondral Allograft Transplantation? A Matched Cohort Study With a Mean Follow-up of 6 Years. Am J Sports Med. 2018. PMID: 29768019. doi:10.1177/0363546518767636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。